索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]张钊,常文凯.手部内生软骨瘤治疗进展[J].国际骨科学杂志,2021,01:26-29.
点击复制

手部内生软骨瘤治疗进展(PDF)

《国际骨科学杂志》[ISSN:1673-7083/CN:31-1952/R]

期数:
2021年01期
页码:
26-29
栏目:
综述
出版日期:
2021-02-10

文章信息/Info

Title:
-
作者:
张钊; 常文凯
030001 太原, 山西医科大学第二医院骨显微手外科
Author(s):
-
关键词:
手;  内生软骨瘤;  骨肿瘤;  治疗进展
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-7083.2021.01.007
文献标识码:
-
摘要:
内生软骨瘤是手部最常见的骨肿瘤,其症状主要为病变部位的肿胀、疼痛和畸形。内生软骨瘤与软骨肉瘤的鉴别诊断较困难。内生软骨瘤的治疗方法可分为保守治疗和手术治疗。目前,对于手术辅助物使用、术后空洞的处理以及合并病理性骨折患者手术时机选择仍存在争议。该文就手部内生软骨瘤的治疗进展进行综述。
Abstract:
-

参考文献/References

[1] Simon MJ, Pogoda P, H?velborn F, et al. Incidence, histopathologic analysis and distribution of tumours of the hand[J]. BMC Musculoskelet Disord, 2014, 15: 182.
[2] Sassoon AA, Fitz-Gibbon PD, Harmsen WS, et al. Enchondromas of the hand: factors affecting recurrence, healing, motion, and malignant transformation[J]. J Hand Surg Am, 2012, 37(6): 1229-1234.
[3] Talbert ML, Zagars GK, Sherman NE, et al. Conservative surgery and radiation therapy for soft tissue sarcoma of the wrist, hand, ankle and foot[J]. Cancer, 1990, 66(12): 2482-2491.
[4] Amary MF, Bacsi K, Maggiani F, et al. IDH1 and IDH2 mutations are frequen events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours[J]. J Pathol, 2011, 224(3): 334-343.
[5] 石宇雄, 漆海如, 黄永明, 等. 手部内生软骨瘤的外科治疗[J]. 中国矫形外科杂志, 2006, 14(15): 1197-1199.
[6] Tang C, Chan M, Fok M, et al. Current management of hand enchondroma: a review[J]. Hand Surg, 2015, 20(1): 191-195.
[7] Takigawa K. Chondroma of the bones of the hand. A review of 110 cases[J]. J Bone Joint Surg Am, 1971, 53(8): 1591-1600.
[8] Mulligan ME. How to diagnose enchondroma, bone infarct, and chondrosarcoma[J]. Curr Probl Diagn Radiol, 2019, 48(3): 262-273.
[9] Janzen L, Logan PM, O'Connell JX, et al. Intramedullary chondroid tumors of bone: correlation of abnormal peritumoral marrow and soft-tissue MRI signal with tumor type[J]. Skeletal Radiol, 1997, 26(2): 100-106.
[10] Douis H, Parry M, Vaiyapuri S, et al. What are the differentiating clinical and MRI-features of enchondromas from low-grade chondrosarcomas?[J]. Eur Radiol, 2018, 28(1): 398-409.
[11] Skeletal Lesions Interobserver Correlation among Expert Diagnosticians(SLICED)Study Group. Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones[J]. J Bone Joint Surg Am, 2007, 89(10): 2113-2123.
[12] Eefting D, Schrage YM, Geirnaerdt MJ, et al. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors[J]. Am J Surg Pathol, 2009, 33(1): 50-57.
[13] Rozeman LB, Cleton-Jansen AM, Hogendoorn PC. Pathology of primary malignant bone and cartilage tumours[J]. Int Orthop, 2006, 30(6): 437-444.
[14] Jo VY, Fletcher CD. WHO classification of soft tissue tumours: an update based on the 2013(4th)edition[J]. Pathology, 2014, 46(2): 95-104.
[15] Jo VY, Doyle LA. Refinements in sarcoma classification in the current 2013 World Health Organization classification of tumours of soft tissue and bone[J]. Surg Oncol Clin N Am, 2016, 25(4): 621-643.
[16] Lubahn JD, Bachoura A. Enchondroma of the hand: evaluation and management[J]. J Am Acad Orthop Surg, 2016, 24(9): 625-633.
[17] Omlor GW, Lohnherr V, Lange J, et al. Outcome of conservative and surgical treatment of enchondromas and atypical cartilaginous tumors of the long bones: retrospective analysis of 228 patients[J]. BMC Musculoskelet Disord, 2019, 28, 20(1): 134.
[18] Deckers C, Schreuder BH, Hannink G, et al. Radiologic follow-up of untreated enchondroma and atypical cartilaginous tumors in the long bones[J]. J Surg Oncol, 2016, 114(8): 987-991.
[19] Crim J, Schmidt R, Layfield L, et al. Can imaging criteria distinguish enchondroma from grade 1 chondrosarcoma?[J]. Eur J Radiol, 2015, 84(11): 2222-2230.
[20] Ferrer-Santacreu EM, Ortiz-Cruz EJ, González-López JM, et al. Enchondroma versus low-grade chondrosarcoma in appendicular skeleton. Clinical and radiological criteria[J]. J Oncol, 2012, 2012: 437958.
[21] Donthineni R, Ofluoglu O. Solitary enchondromas of long bones: pattern of referral and outcome[J]. Acta Orthop Traumatol Turc, 2010, 44(5): 397-402.
[22] Müller PE, Dürr HR, Wegener B, et al. Solitary enchondromas: is radiographic follow-up suffificient in patients with asymptomatic lesions?[J]. Acta Orthop Belg, 2003, 69(2): 112-118.
[23] Schaller P, Baer W. Operative treatment of enchondromas of the hand: is cancellous bone grafting necessary?[J]. Scand J Plast Reconstr Surg Hand Surg, 2009, 43(5): 279-285.
[24] Morii T, Mochizuki K, Tajima T, et al. Treatment outcome of enchondroma by simple curettage without augmentation[J]. J Oryhop Sci, 2010, 15(1): 112-117.
[25] Azar FM. Tissue processing: role of secondary sterilization techniques[J]. Clin Sports Med, 2009, 28(2): 191-201.
[26] Yercan H, Ozalp T, Cokunol E, et al. Long-term results of autograft and allograft applications in hand enchondromas[J]. Acta Orthop Traumatol Turc, 2004, 38(5): 337-342.
[27] Knaack S, Lode A, Hoyer B, et al. Heparin modification of a biomimetic bone matrix for controlled release of VEGF[J]. J Biomed Mater Res A, 2014, 102(10): 3500-3511.
[28] Rajeh MA, Diaz JJ, Facca S, et al. Treatment of hand enchondroma with injectable calcium phosphate cement: a series of eight cases[J]. Eur J Orthop Surg Trumatol, 2017, 27(2): 251-254.
[29] Yasuda M, Masada K, Takeuchi E. Treatment of enchondroma of the hand with injectable calcium phosphate bone cement[J]. J Hand Surg Am, 2006, 31(1): 98-102.
[30] Gaasbeek RD, Rijnberg WJ, van Loon CJ, et al. No local recurrence of enchondroma after curettage and plaster filling[J]. Arch Orthop Trauma Surg, 2005, 125(1): 42-45.
[31] Zhang X, Kang T, Liang P, et al. Biological activity of an injectable biphasic calcium phosphate/pmma bone cement for induced osteogensis in rabbit model[J]. Macromol Biosci, 2018, 18(3). doi: 10.1002/mabi.201700331.
[32] Fang CH, Lin YW, Sun JS, et al. The chitosan/tri-calcium phosphate bio-composite bone cement promotes better osteo-integration: an in vitro and in vivo study[J]. J Orthop Surg Res, 2019, 14(1): 162.
[33] Zhai Q, Han F, He Z, et al. The "Magnesium Sacrifice" strategy enables PMMA bone cement partial biodegradability and osseointegration potential[J]. Int J Mol Sci, 2018, 19(6): 1746.
[34] Cha SM, Shin HD, Kim KC, et al. Extensive curettage using a high-speed burr versus dehydrated alcohol instillation for the treatment of enchondroma of the hand[J]. J Hand Surg Eur Vol, 2015, 40(4): 384-391.
[35] Ablove RH, Moy OJ, Peimer CA, et al. Early versus delayed treatment of enchondroma[J]. Am J Orthop(Belle Mead NJ), 2000, 29(10): 771-772.
[36] 郑炜, 熊革, 李淳, 等. 合并病理性骨折的手部单发内生软骨瘤疗效影响因素分析[J]. 中国修复重建外科杂志, 2014, 28(7): 840-843.
[37] Lin SY, Huang PJ, Huang HT, et al. An alternative technique for the management of phalangeal enchondromas with pathologic fractures[J]. J Hand Surg Am, 2013, 38(1): 104-109.
[38] Dietz JF, Kachar SM, Nagle DJ. Endoscopically assisted excision of digital enchondroma[J]. Arthroscopy, 2007, 23(6): 678.
[39] Choi Y, Kwak JM, Chung SH, et al. Tumor treated by endoscopy[J]. Clin Orthop Surg, 2014, 6(1): 72-79.

备注/Memo

备注/Memo:
作者单位: 030001 太原, 山西医科大学第二医院骨显微手外科
通信作者: 常文凯 E-mail: 820671441@qq.com
更新日期/Last Update: 2021-02-10